Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Wall Street
Price Targets
Price Targets Summary
Shenzhen Hepalink Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Shenzhen Hepalink Pharmaceutical Group Co Ltd is 8.77 CNY with a low forecast of 8.69 CNY and a high forecast of 9.03 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's stock price target?
Price Target
8.77
CNY
According to Wall Street analysts, the average 1-year price target for Shenzhen Hepalink Pharmaceutical Group Co Ltd is 8.77 CNY with a low forecast of 8.69 CNY and a high forecast of 9.03 CNY.
What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
8%
For the last 13 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 8%.
What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
20%
For the last 13 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is 20%.
What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
16%
For the last 13 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 16%.
